Usfulness of cholesterol in difering malignant and nonmalignant pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 246s Year: 2004
Pleural fluid, serum β-HCG levels and pleural fluid/serum β-HCG ratio for the discrimination of malignant and benign pleural effusions Source: Eur Respir J 2003; 22: Suppl. 45, 60s Year: 2003
Diagnostic value of amylase levels in pleural effusions Source: Eur Respir J 2005; 26: Suppl. 49, 448s Year: 2005
Diagnostic value of procalcitonin and C-reactive protein in the differentiation among bening and malignant pleural effusion Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009
Diagnostic utility of pleural CEA and CYFRA 21-1 for malignant pleural effusions Source: Eur Respir J 2003; 22: Suppl. 45, 60s Year: 2003
Comparison and relationship of cholesterol and lipoproteins of pleural effusions with serum levels of them in exudative and transudative pleural fluid Source: Eur Respir J 2005; 26: Suppl. 49, 446s Year: 2005
Evaluation of pleural fluid human epididymis 4 (HE4) as a marker of malignant pleural effusions Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions Year: 2012
Prognostic significance of serum and pleural mesothelin in malignant pleural mesothelioma (MPM) Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017
Diagnostic value of lactatedehydrogenase in pleural effusions Source: Eur Respir J 2002; 20: Suppl. 38, 441s Year: 2002
Diagnostic usefulness of C reactive protein levels in pleural effusions of malignant and non malignant origin Source: Eur Respir J 2007; 30: Suppl. 51, 431s Year: 2007
Diagnostic value of lactate dehydrogenase (LDH) pleural fluid (PF)/serum (S) ratio in the differential diagnosis of pleural exudates Source: Eur Respir J 2002; 20: Suppl. 38, 441s Year: 2002
Evaluation of pleural fluid total protein, albumin, globulin levels and albumin/globulin ratios in the differential diagnosis of pleural effusions Source: International Congress 2016 – From pleura to bronchi: new insights Year: 2016
Can serum (CRP) levels estimate the outome of talc pleurodesis in malignant pleural effusions? Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions Year: 2012
Diagnostic value of pleural fluid angiopoietin-2 (Ang-2) levels, to differentiate malignant pleural effusions from benign pleural effusions Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016
Diagnostic efficiency of pleural fluid lipid-bound sialic acid level in malignant pleural effusions Source: Eur Respir J 2002; 20: Suppl. 38, 439s Year: 2002
Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer with malignant pleural effusions Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology Year: 2012
The usefulness of Cyfra 21-1 as a disease marker in malignant pleural mesothelioma (MPM) Source: Eur Respir J 2006; 28: Suppl. 50, 85s Year: 2006
Diagnostic value of ADA total and ADA2 isoenzyme and 2‘deoxyadenosin/ADA ratio in tuberculous pleural effusion in Iran Source: Eur Respir J 2005; 26: Suppl. 49, 687s Year: 2005
The diagnostic value of NO-metabolites (nitrate/nitrite) in pleural effusion Source: Eur Respir J 2005; 26: Suppl. 49, 447s Year: 2005
Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019